Cempra Inc. (CEMP) News Nov 20, 2014, 5:14 p.m. M
Post# of 250601
Posted On: 11/21/2014 2:16:02 AM
Cempra Inc. (CEMP) News Nov 20, 2014, 5:14 p.m.
MarketWatch News on CEMP
Cempra's 7.25 Million shares sold at 14% discount 10:13 a.m. June 14, 2013 - MarketWatch.com
Modest gains for Cempra's IPO in trading debut 1:27 p.m. Feb. 3, 2012 - MarketWatch.com
Other News on CEMP
Thinking Differently About Ebola Virus Disease: WBB Securities' Steve Brozak 4:24 p.m. Nov. 13, 2014 - Seeking Alpha
Sucampo (SCMP) Worth Watching: Stock Moves 7.4% Higher - Tale of the Tape 9:25 a.m. Nov. 13, 2014 - Zacks.com
Moving Average Crossover Alert: Cempra (CEMP) - Tale of the Tape 9:10 a.m. Nov. 6, 2014 - Zacks.com
Why Cempra (CEMP) Could Be Positioned for a Surge? - Tale of the Tape 8:31 a.m. Nov. 6, 2014 - Zacks.com
Moving Average Crossover Alert: Cempra (CEMP) - Tale of the Tape 6:16 a.m. Nov. 4, 2014 - Zacks.com
Strength Seen in Cempra (CEMP): Stock Rises 10.1% - Tale of the Tape 9:25 a.m. Oct. 31, 2014 - Zacks.com
Cempra's (CEMP) CEO Prabha Fernandes on Q3 2014 Results - Earnings Call Transcript 11:16 p.m. Oct. 29, 2014 - Seeking Alpha
10-Q: CEMPRA, INC. 4:08 p.m. Oct. 29, 2014 - Edgar Online - (EDG = 10Q, 10K)
Notable earnings after Wednesday’s close 5:35 p.m. Oct. 28, 2014 - Seeking Alpha
La Jolla Pharmaceutical Co. (LJPC) Jumps: Stock Rises 10.3% - Tale of the Tape 9:32 a.m. Oct. 27, 2014 - Zacks.com
Strength Seen in Regulus (RGLS): Stock Soars 103.1% - Tale of the Tape 9:25 a.m. Oct. 23, 2014 - Zacks.com
Corium International (CORI) Jumps: Stock Adds 8.9% - Tale of the Tape 9:52 a.m. Oct. 22, 2014 - Zacks.com
Enanta (ENTA) Worth Watching: Stock Moves 6.9% Higher - Tale of the Tape 9:41 a.m. Oct. 21, 2014 - Zacks.com
ImmunoGen (IMGN) in Focus: Stock Rallies 14% - Tale of the Tape 8:44 a.m. Oct. 21, 2014 - Zacks.com
Tetraphase (TTPH) in Focus: Stock Gains 19.9% - Tale of the Tape 9:46 a.m. Oct. 20, 2014 - Zacks.com
ChemoCentryx, Inc. (CCXI) in Focus: Stock Rises 9.6% - Tale of the Tape 9:32 a.m. Oct. 17, 2014 - Zacks.com
Aquinox Pharmaceuticals (AQXP) Jumps: Stock Soars 22.4% - Tale of the Tape 9:27 a.m. Oct. 17, 2014 - Zacks.com
Tetraphase (TTPH) Crumbles: Stock Tanks by 15% - Tale of the Tape 8:55 a.m. Oct. 17, 2014 - Zacks.com
BioCryst Pharmaceuticals (BCRX) Jumps: Stock Up 14.7% - Tale of the Tape 9:25 a.m. Oct. 16, 2014 - Zacks.com
Corcept Therapeutics (CORT) Jumps: Stock Rises 6.4% - Tale of the Tape 9:32 a.m. Oct. 15, 2014 - Zacks.com
Press Releases on CEMP
Cempra to Receive BARDA Funding for 1b and Start-Up of Phase 2/3 Solithromycin Pediatric Studies 6:01 a.m. Nov. 19, 2014 - GlobeNewswire
Cempra to Present at Two Upcoming Investor Conferences 4:07 p.m. Nov. 10, 2014 - GlobeNewswire
Cempra Reports Third Quarter 2014 Financial Results and Provides Corporate Update 3:07 p.m. Oct. 29, 2014 - GlobeNewswire
Cempra Completes Enrollment of Solitaire-Oral Phase 3 Trial 3:05 p.m. Sept. 25, 2014 - GlobeNewswire
Cempra, Inc. Receives $10 Million Milestone Payment From Toyama Chemical Co. Triggered by Solithromycin's Clinical Development Progress in Japan 7:01 a.m. Sept. 9, 2014 - GlobeNewswire
Cempra, Inc. to Present at Three Investor Conferences 3:06 p.m. Aug. 27, 2014 - GlobeNewswire
Cempra Initiates Phase 3 Clinical Trial in Patients With Uncomplicated Gonorrhea Infection 7:01 a.m. Aug. 12, 2014 - GlobeNewswire
Cempra, Inc. Reports Second Quarter 2014 Financial and Operating Results 3:06 p.m. July 29, 2014 - GlobeNewswire
Cempra, Inc. to Report Second Quarter 2014 Financial and Operating Results, and Host Conference Call and Webcast on July 29, 2014 3:06 p.m. July 22, 2014 - GlobeNewswire
Cempra, Inc. to Present at JMP Securities Healthcare Conference 3:05 p.m. June 17, 2014 - GlobeNewswire
Wall Street In and Out of Love with NASH Drug Developers 9:21 a.m. May 13, 2014 - ACCESSWIRE
Cempra, Inc. to Present at Three Investor Conferences 3:01 p.m. May 8, 2014 - GlobeNewswire
Cempra, Inc. Reports First Quarter 2014 Financial and Operating Results 3:02 p.m. April 29, 2014 - GlobeNewswire
Cempra, Inc. to Report First Quarter 2014 Financial and Operating Results, and Host Conference Call and Webcast on April 29, 2014 3:06 p.m. April 22, 2014 - GlobeNewswire
Treatments for Non-Alcoholic Steatohepatitis Making Clinical Strides 10:01 a.m. April 8, 2014 - ACCESSWIRE
Cempra's Solithromycin Demonstrates Therapeutic Potential Beyond Anti-Bacterial Activity 3:06 p.m. April 3, 2014 - GlobeNewswire
Cempra to Present Late-Breaker on Solithromycin Reducing Inflammation in an Animal Model for Cancer Chemotherapy-Induced Lung Injury 7:14 a.m. March 27, 2014 - GlobeNewswire
Cempra, Inc. to Present at The 21st Annual Future Leaders in the Biotech Industry Conference and Needham & Co. 12th Annual Healthcare Conference 3:12 p.m. March 20, 2014 - GlobeNewswire
Cempra, Inc. to Present at Barclays Capital 2014 Global Healthcare Conference and 26th Annual ROTH Conference 3:59 a.m. March 7, 2014 - GlobeNewswire
Cempra, Inc. Reports Fourth Quarter and Full Year 2013 Financial and Operating Results 4:15 p.m. Feb. 27, 2014 - GlobeNewswire
MarketWatch News on CEMP
Cempra's 7.25 Million shares sold at 14% discount 10:13 a.m. June 14, 2013 - MarketWatch.com
Modest gains for Cempra's IPO in trading debut 1:27 p.m. Feb. 3, 2012 - MarketWatch.com
Other News on CEMP
Thinking Differently About Ebola Virus Disease: WBB Securities' Steve Brozak 4:24 p.m. Nov. 13, 2014 - Seeking Alpha
Sucampo (SCMP) Worth Watching: Stock Moves 7.4% Higher - Tale of the Tape 9:25 a.m. Nov. 13, 2014 - Zacks.com
Moving Average Crossover Alert: Cempra (CEMP) - Tale of the Tape 9:10 a.m. Nov. 6, 2014 - Zacks.com
Why Cempra (CEMP) Could Be Positioned for a Surge? - Tale of the Tape 8:31 a.m. Nov. 6, 2014 - Zacks.com
Moving Average Crossover Alert: Cempra (CEMP) - Tale of the Tape 6:16 a.m. Nov. 4, 2014 - Zacks.com
Strength Seen in Cempra (CEMP): Stock Rises 10.1% - Tale of the Tape 9:25 a.m. Oct. 31, 2014 - Zacks.com
Cempra's (CEMP) CEO Prabha Fernandes on Q3 2014 Results - Earnings Call Transcript 11:16 p.m. Oct. 29, 2014 - Seeking Alpha
10-Q: CEMPRA, INC. 4:08 p.m. Oct. 29, 2014 - Edgar Online - (EDG = 10Q, 10K)
Notable earnings after Wednesday’s close 5:35 p.m. Oct. 28, 2014 - Seeking Alpha
La Jolla Pharmaceutical Co. (LJPC) Jumps: Stock Rises 10.3% - Tale of the Tape 9:32 a.m. Oct. 27, 2014 - Zacks.com
Strength Seen in Regulus (RGLS): Stock Soars 103.1% - Tale of the Tape 9:25 a.m. Oct. 23, 2014 - Zacks.com
Corium International (CORI) Jumps: Stock Adds 8.9% - Tale of the Tape 9:52 a.m. Oct. 22, 2014 - Zacks.com
Enanta (ENTA) Worth Watching: Stock Moves 6.9% Higher - Tale of the Tape 9:41 a.m. Oct. 21, 2014 - Zacks.com
ImmunoGen (IMGN) in Focus: Stock Rallies 14% - Tale of the Tape 8:44 a.m. Oct. 21, 2014 - Zacks.com
Tetraphase (TTPH) in Focus: Stock Gains 19.9% - Tale of the Tape 9:46 a.m. Oct. 20, 2014 - Zacks.com
ChemoCentryx, Inc. (CCXI) in Focus: Stock Rises 9.6% - Tale of the Tape 9:32 a.m. Oct. 17, 2014 - Zacks.com
Aquinox Pharmaceuticals (AQXP) Jumps: Stock Soars 22.4% - Tale of the Tape 9:27 a.m. Oct. 17, 2014 - Zacks.com
Tetraphase (TTPH) Crumbles: Stock Tanks by 15% - Tale of the Tape 8:55 a.m. Oct. 17, 2014 - Zacks.com
BioCryst Pharmaceuticals (BCRX) Jumps: Stock Up 14.7% - Tale of the Tape 9:25 a.m. Oct. 16, 2014 - Zacks.com
Corcept Therapeutics (CORT) Jumps: Stock Rises 6.4% - Tale of the Tape 9:32 a.m. Oct. 15, 2014 - Zacks.com
Press Releases on CEMP
Cempra to Receive BARDA Funding for 1b and Start-Up of Phase 2/3 Solithromycin Pediatric Studies 6:01 a.m. Nov. 19, 2014 - GlobeNewswire
Cempra to Present at Two Upcoming Investor Conferences 4:07 p.m. Nov. 10, 2014 - GlobeNewswire
Cempra Reports Third Quarter 2014 Financial Results and Provides Corporate Update 3:07 p.m. Oct. 29, 2014 - GlobeNewswire
Cempra Completes Enrollment of Solitaire-Oral Phase 3 Trial 3:05 p.m. Sept. 25, 2014 - GlobeNewswire
Cempra, Inc. Receives $10 Million Milestone Payment From Toyama Chemical Co. Triggered by Solithromycin's Clinical Development Progress in Japan 7:01 a.m. Sept. 9, 2014 - GlobeNewswire
Cempra, Inc. to Present at Three Investor Conferences 3:06 p.m. Aug. 27, 2014 - GlobeNewswire
Cempra Initiates Phase 3 Clinical Trial in Patients With Uncomplicated Gonorrhea Infection 7:01 a.m. Aug. 12, 2014 - GlobeNewswire
Cempra, Inc. Reports Second Quarter 2014 Financial and Operating Results 3:06 p.m. July 29, 2014 - GlobeNewswire
Cempra, Inc. to Report Second Quarter 2014 Financial and Operating Results, and Host Conference Call and Webcast on July 29, 2014 3:06 p.m. July 22, 2014 - GlobeNewswire
Cempra, Inc. to Present at JMP Securities Healthcare Conference 3:05 p.m. June 17, 2014 - GlobeNewswire
Wall Street In and Out of Love with NASH Drug Developers 9:21 a.m. May 13, 2014 - ACCESSWIRE
Cempra, Inc. to Present at Three Investor Conferences 3:01 p.m. May 8, 2014 - GlobeNewswire
Cempra, Inc. Reports First Quarter 2014 Financial and Operating Results 3:02 p.m. April 29, 2014 - GlobeNewswire
Cempra, Inc. to Report First Quarter 2014 Financial and Operating Results, and Host Conference Call and Webcast on April 29, 2014 3:06 p.m. April 22, 2014 - GlobeNewswire
Treatments for Non-Alcoholic Steatohepatitis Making Clinical Strides 10:01 a.m. April 8, 2014 - ACCESSWIRE
Cempra's Solithromycin Demonstrates Therapeutic Potential Beyond Anti-Bacterial Activity 3:06 p.m. April 3, 2014 - GlobeNewswire
Cempra to Present Late-Breaker on Solithromycin Reducing Inflammation in an Animal Model for Cancer Chemotherapy-Induced Lung Injury 7:14 a.m. March 27, 2014 - GlobeNewswire
Cempra, Inc. to Present at The 21st Annual Future Leaders in the Biotech Industry Conference and Needham & Co. 12th Annual Healthcare Conference 3:12 p.m. March 20, 2014 - GlobeNewswire
Cempra, Inc. to Present at Barclays Capital 2014 Global Healthcare Conference and 26th Annual ROTH Conference 3:59 a.m. March 7, 2014 - GlobeNewswire
Cempra, Inc. Reports Fourth Quarter and Full Year 2013 Financial and Operating Results 4:15 p.m. Feb. 27, 2014 - GlobeNewswire
(0)
(0)Scroll down for more posts ▼